Joseph J. Krivulka

Plus aucun poste en cours

Profil

Joseph J.
Krivulka founded Reliant Pharmaceuticals LLC in 1999, where he worked as President in 2004, Akrimax Pharmaceuticals LLC in 2007, where he worked as Chairman & Chief Executive Officer from 2007 to 2018, and Triax Pharmaceuticals LLC in 2004, where he worked as President & Chief Executive Officer in 2011.
Mr. Krivulka also founded Rouses Point Pharmaceuticals LLC, where he worked as Chairman and MIST Pharmaceuticals LLC, where he worked as Chairman.
Mr. Krivulka also formerly worked at Mylan Technologies, Inc., as Chief Executive Officer, Bertek, Inc., as Chief Executive Officer, Nektar Therapeutics, as Independent Director from 2011 to 2018, Biovail Corp., as Director, Incara Pharmaceuticals Corp., as Director, Aeolus Pharmaceuticals, Inc., as Independent Director from 2011 to 2013, Ambrilia Biopharma, Inc., as Director from 2006 to 2007, Prismic Pharmaceuticals, Inc., as Director, Aerami Therapeutics, Inc., as Director in 2014, Mylan Laboratories, Inc., as Vice President, and Mylan, Inc., as Corporate Vice President.
Mr. Krivulka received his undergraduate degree from West Virginia Wesleyan College.

Anciens postes connus de Joseph J. Krivulka

Sociétés	Poste	Fin
NEKTAR THERAPEUTICS	Directeur/Membre du Conseil	17/02/2018
Akrimax Pharmaceuticals LLC	Directeur Général	17/02/2018
Rouses Point Pharmaceuticals LLC	Fondateur	17/02/2018
MIST Pharmaceuticals LLC	Fondateur	17/02/2018
AEOLUS PHARMACEUTICALS, INC.	Directeur/Membre du Conseil	08/05/2013